fig3

Figure 3. Systemic treatment algorithm proposed by the authors. Therapeutical regimens should be selected in adaption to patients’ comorbidities, liver function, tumor burden/localization, AFP level, and tolerance to previous systemic treatment. AFP: Alpha-fetoprotein.